Home » Topics » BioWorld Science

BioWorld Science
RSS

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

New agents for heart disease prepared by Dainippon Ink & Chemicals

Nov. 26, 1997

Milestone reached in antiinfectives alliance

Nov. 26, 1997

ProLease hGH slated to enter phase III

Nov. 26, 1997

ImmuLogic restructures its operations

Nov. 26, 1997

Sertoli and Carolinas Medical Center collaborate to develop novel diabetes therapy

Nov. 26, 1997

NINDS study links herpesvirus strain to MS

Nov. 26, 1997

Results from Leuvectin trial in kidney cancer patients reported

Nov. 26, 1997

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...